ARCA biopharma Inc (HQ10) News

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Form 8-K - Current report

Tellurian to be Acquired by Woodside for Approximately $900 Million

All-cash transaction provides substantial and certain value to Tellurian shareholders Offer reflects new leadership’s progress executing the...

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Tellurian Closes $260 Million Asset Sale and Retires Senior Secured Debt

  Tellurian Inc. (Tellurian or the Company) (NYSE American: TELL) announced today that it has closed the previously reported sale of its...

Aethon Energy to Acquire Tellurian Integrated Upstream Assets

Enters into Heads of Agreement for Two mtpa of LNG from Driftwood LNG Tellurian Inc. (NYSE American: TELL) and Aethon Energy Management LLC...

Tellurian reports first quarter 2024 results and Driftwood LNG progress

Tellurian Inc. (Tellurian or the Company) (NYSE American: TELL) continued making progress on Driftwood LNG phase one construction with Bechtel...

Tellurian Makes Leadership Changes

Tellurian Inc. (Tellurian) (NYSE American: TELL) announced today the following leadership changes: Executive Vice President and President of...

Form 8-K - Current report

Form 8-K - Current report

Tellurian Reports 2023 Financial Results and Driftwood LNG Progress

Tellurian Inc. (Tellurian or the Company) (NYSE American: TELL) reported its full year 2023 financial results today. During 2023, Tellurian took...

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]